Platelet Count Predicts Adverse Clinical Outcomes After Ischemic Stroke or TIA: Subgroup Analysis of CNSR II.

Ming Yang,Hongyi Yan,Yuesong Pan,Yongjun Wang,Zixiao Li,Yilong Wang,Xia Meng,Jing Jing,Liping Liu,Xingquan Zhao

doi:10.3389/fneur.2019.00370

Abstract

Background: The clinical significance of platelet count (PC) for ischemic cerebrovascular disease is not well-established and further risk stratification according to baseline PC within normal range has not been reported before. We aim to evaluate the prognostic effect of baseline circulating PC within normal range on the risk of long-term recurrent stroke, mortality and functional outcomes after ischemic stroke or TIA.Methods: We derived data from eligible patients with ischemic stroke or TIA from the China National Stroke Registry (CNSR) II. Participants were divided into quintiles according to baseline PC within normal range (100–450 × 109/L). Multivariable cox regression and logistic regression were adopted to explore the correlation of baseline PC with recurrent stroke, mortality and poor functional outcomes (modified Rankin Scale 3~6) within 1-year follow-up.Results: Among the16842 eligible participants, the average age was 64.7 ± 11.9, 1,241 (7.4%) had recurrent stroke, 1,377 (8.2%) died, and 3,557 (21.1%) ended up with poor functional outcomes after 1-year follow-up. Compared with the third PC quintile (186–212 × 109/L), patients in the top quintile (249–450 × 109/L) presented with increased risk of recurrent stroke (adjusted hazard ratio 1.21, [1.02–1.45]), all-cause mortality (adjusted hazard ratio 1.43, [1.19–1.73]), and poor functional outcome (adjusted odds ratio 1.49, [1.28–1.74]), while patients in the lowest PC quintile(100–155 × 109/L) had higher risk of poor functional outcome (adjusted odds ratio 1.19, [1.02–1.38]).Conclusion: In ischemic stroke or TIA patients with platelet count within normal range, platelet count may be a qualified predictor for long-term recurrent stroke, mortality, and poor functional outcome.

Highlights

Platelets exert a critical role in the pathogenesis of atherosclerotic complications of cardio-cerebrovascular disease, contributing to thrombus formation, and embolism [1, 2]
The clinical significance of platelet count (PC), especially for ischemic cerebrovascular disease, is not wellestablished and further risk stratification according to baseline PC within normal range for ischemic stroke or transient ischemic attack (TIA) patients has not been reported before
This study primarily aimed to explore the prognostic significance of baseline PC within normal range on long-term follow-up clinical outcomes for ischemic stroke or TIA patients through a nationwide prospective registry study

Summary

Introduction

Platelets exert a critical role in the pathogenesis of atherosclerotic complications of cardio-cerebrovascular disease, contributing to thrombus formation, and embolism [1, 2]. The clinical significance of PC, especially for ischemic cerebrovascular disease, is not wellestablished and further risk stratification according to baseline PC within normal range for ischemic stroke or TIA patients has not been reported before. These preliminary findings and the important role of platelets in the pathophysiology of atherosclerosis probably qualify platelet count an available and novel prognostic biomarker for ischemic cerebrovascular disease, though not as definitive conclusions. The clinical significance of platelet count (PC) for ischemic cerebrovascular disease is not well-established and further risk stratification according to baseline PC within normal range has not been reported before. We aim to evaluate the prognostic effect of baseline circulating PC within normal range on the risk of long-term recurrent stroke, mortality and functional outcomes after ischemic stroke or TIA

Objectives

Methods

Results

Discussion

Conclusion